トラベルワクチンの市場規模、シェア、成長分析、成分別、投与経路別、疾患別、旅行タイプ別、年齢層別、地域別 - 産業予測 2025～2032年

トラベルワクチンの世界市場規模は2023年に51億9,000万米ドルと評価され、2024年の57億4,000万米ドルから2032年には119億3,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは9.6％で成長する見通しです。

世界のトラベルワクチン市場は、健康意識の高まり、海外旅行の増加、政府による積極的なワクチン接種の取り組みによって著しい成長を遂げています。消費者が感染症から健康を守ることを優先するようになり、予防対策への需要が顕著になり、ワクチン開発と供給における技術革新が推進されています。パンデミック後の渡航動向は、特に黄熱病やA型肝炎などの疾病に対するワクチン接種の緊急性を高めており、多くの国が入国時にワクチン接種の証明を義務付けています。新興経済諸国では、医療インフラの整備が遅れているため、ワクチン需要が急増しています。しかし、ワクチン保管のためのコールドチェーンロジスティクスや規制の複雑さといった課題は依然として残っています。このようなハードルにもかかわらず、政府、NGO、民間セクターの協力は、市場の発展とアクセスの障壁の克服に不可欠です。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 供給と需要の動向分析
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• パイプライン分析
• 特許分析
• 価格分析
• FDA分析
• ケーススタディ分析
• 技術評価

トラベルワクチン市場規模：成分別& CAGR（2025-2032）

• 市場概要
• モノワクチン
• 混合ワクチン

トラベルワクチン市場規模：投与経路別& CAGR（2025-2032）

• 市場概要
• 注射ワクチン
• 鼻腔内ワクチン
• 経口ワクチン

トラベルワクチン市場規模：疾患別& CAGR（2025-2032）

• 市場概要
• A型肝炎
• 黄熱病
• 腸チフス
• B型肝炎
• 麻疹とおたふく風邪
• 狂犬病
• インフルエンザ
• その他

トラベルワクチン市場規模：旅行タイプ別& CAGR（2025-2032）

• 市場概要
• 国内
• 国外

トラベルワクチン市場規模：年齢層別& CAGR（2025-2032）

• 市場概要
• 乳幼児
• 成人
• 高齢者

トラベルワクチン市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024年）

主要企業プロファイル

• Pfizer
• Sanofi
• GlaxoSmithKline
• Merck & Co., Inc.
• AstraZeneca
• Abbott Laboratories
• F. Hoffmann-La Roche AG
• Takeda Pharmaceutical
• VBI Vaccine Inc.
• Bavarian Nordic
• CSL
• Valneva SE
• Johnson & Johnson Services Inc.（Crucell）
• Dynavax Technologies
• Novartis AG
• Bharat Biotech
• Emergent BioSolutions
• Hualan Biological Engineering Inc.
• Serum Institute of India Pvt. Ltd.
• Zydus Group

結論と提言

Global Travel Vaccines market size was valued at USD 5.19 Billion in 2023 and is poised to grow from USD 5.74 Billion in 2024 to USD 11.93 Billion by 2032, growing at a CAGR of 9.6% during the forecast period (2025-2032).

The global travel vaccine market is experiencing remarkable growth driven by heightened health awareness, increased international travel, and proactive government vaccination initiatives. As consumers prioritize health protection against infectious diseases, there's a notable demand for preventative measures, propelling innovation in vaccine development and delivery. Post-pandemic travel trends have enhanced the urgency for vaccinations, particularly for diseases like yellow fever and hepatitis A, with many countries imposing vaccination proof for entry. Emerging economies are seeing a surge in vaccine demand due to less developed health infrastructures. Yet, challenges such as cold-chain logistics for vaccine storage and regulatory complexities persist. Despite these hurdles, collaboration among governments, NGOs, and the private sector is crucial for market advancement and overcoming access barriers.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Travel Vaccines market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Travel Vaccines Market Segments Analysis

The global Travel Vaccines Market is segmented by Composition, Administration Route, Diseases, Travel Type, Age Group and region. Based on Composition, the market is segmented into Mono Vaccines and Combination Vaccines. Based on Administration Route, the market is segmented into Injectable Vaccines, Intranasal Vaccines and Oral Vaccines. Based on Diseases, the market is segmented into Hepatitis A, Yellow Fever, Typhoid, Hepatitis B, Measles & Mumps, Rabies, Influenza and Others. Based on Travel Type, the market is segmented into Domestic and Outbound. Based on Age Group, the market is segmented into Infants & Children, Adults and Elderly. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Travel Vaccines Market

The global travel vaccines market is significantly driven by the resurgence of international tourism, which has seen a remarkable recovery post-pandemic. In 2023, the UNWTO reported that international tourist arrivals climbed to 1.29 billion, marking a notable rebound. Countries such as Saudi Arabia and Australia have implemented strict vaccination requirements for travelers coming from endemic areas, specifically for diseases like yellow fever. This regulatory push has heightened the necessity for travel vaccines, resulting in impressive revenue growth for pharmaceutical companies. For instance, Sanofi highlighted a 10.4% increase in travel vaccine revenues in their 2023 annual report, illustrating the growing demand fueled by health regulations.

Restraints in the Global Travel Vaccines Market

The Global Travel Vaccines market faces significant constraints primarily due to the high out-of-pocket costs associated with these vaccines, which can deter individuals from seeking them. As reported by the CDC in 2023, common vaccines such as yellow fever and typhoid can range from $150 to $350 per dose, and most insurance plans do not cover these expenses. Companies, including Emergent BioSolutions, highlighted in their 2023 Annual Report that the affordability of vaccines is a major hurdle for broader market acceptance, especially among cost-sensitive travelers in developing nations. This financial barrier limits access and reduces the overall uptake of essential travel immunizations.

Market Trends of the Global Travel Vaccines Market

The Global Travel Vaccines market is experiencing a notable upward trend, particularly driven by heightened demand for COVID-19 booster doses as international travel regulations become increasingly stringent. With countries such as the U.S. and those in the EU enforcing updated vaccination requirements for travelers, pharmaceutical giants like Pfizer and Moderna are scaling production to meet this surge. Analysts project that sales of COVID-19 booster shots are set to grow by 15-20% in 2024, propelled by guidelines from authorities like the CDC, which emphasize the importance of booster vaccinations for individuals traveling to high-risk regions. This trend highlights the evolving landscape of travel health and safety.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Supply & Demand Trend Analysis
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Pipeline Analysis
• Patent Analysis
• Pricing Analysis
• FDA Analysis
• Case Study Analysis
• Technology Assessment

Global Travel Vaccines Market Size by Composition & CAGR (2025-2032)

• Market Overview
• Mono Vaccines
• Combination Vaccines

Global Travel Vaccines Market Size by Administration Route & CAGR (2025-2032)

• Market Overview
• Injectable Vaccines
• Intranasal Vaccines
• Oral Vaccines

Global Travel Vaccines Market Size by Diseases & CAGR (2025-2032)

• Market Overview
• Hepatitis A
• Yellow Fever
• Typhoid
• Hepatitis B
• Measles & Mumps
• Rabies
• Influenza
• Others

Global Travel Vaccines Market Size by Travel Type & CAGR (2025-2032)

• Market Overview
• Domestic
• Outbound

Global Travel Vaccines Market Size by Age Group & CAGR (2025-2032)

• Market Overview
• Infants & Children
• Adults
• Elderly

Global Travel Vaccines Market Size & CAGR (2025-2032)

• North America (Composition, Administration Route, Diseases, Travel Type, Age Group)
  • US
  • Canada
• Europe (Composition, Administration Route, Diseases, Travel Type, Age Group)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Composition, Administration Route, Diseases, Travel Type, Age Group)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Composition, Administration Route, Diseases, Travel Type, Age Group)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Composition, Administration Route, Diseases, Travel Type, Age Group)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Pfizer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VBI Vaccine Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bavarian Nordic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CSL
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Valneva SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Services Inc. (Crucell)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dynavax Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bharat Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emergent BioSolutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hualan Biological Engineering Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Serum Institute of India Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zydus Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations